Samuel P Wertheimer - Net Worth and Insider Trading

Samuel P Wertheimer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samuel P Wertheimer owns 4 companies in total, including Albireo Pharma Inc (ALBO) , Brookline Capital Acquisition Corp (BCAC) , and Apexigen Inc (APGN) among others .

Click here to see the complete history of Samuel P Wertheimer’s form 4 insider trades.

Insider Ownership Summary of Samuel P Wertheimer

Ticker	Comapny	Transaction Date	Type of Owner
ALBO	Albireo Pharma Inc	2007-05-10	director
BCAC	Brookline Capital Acquisition Corp	2021-01-28	director & Chief Executive Officer
APGN	Apexigen Inc	2022-07-29	director
BCACU	Brookline Capital Acquisition Corp	2022-07-29	director

Samuel P Wertheimer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Samuel P Wertheimer Ownership Network

Ownership Network List of Samuel P Wertheimer

No Data

Ownership Network Relation of Samuel P Wertheimer

Samuel P Wertheimer Owned Company Details

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

Samuel P Wertheimer is the director of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

Over the past 18 months, Samuel P Wertheimer made no insider transaction in Albireo Pharma Inc (ALBO). Other recent insider transactions involving Albireo Pharma Inc (ALBO) include a net sale of 2,814 shares made by Pamela Stephenson , a net sale of 3,285 shares made by Jan Mattsson , and a net sale of 1,878 shares made by Harford Simon N.r. .

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,134 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,134 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Albireo Pharma Inc Insider Transactions

No Available Data

What does Brookline Capital Acquisition Corp do?

Who are the key executives at Brookline Capital Acquisition Corp?

Samuel P Wertheimer is the director & Chief Executive Officer of Brookline Capital Acquisition Corp. Other key executives at Brookline Capital Acquisition Corp include 10 percent owner Glazer Capital, Llc , 10 percent owner Paul J Glazer , and director & President Scott A Katzmann .

Brookline Capital Acquisition Corp (BCAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Brookline Capital Acquisition Corp (BCAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Brookline Capital Acquisition Corp (BCAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Brookline Capital Acquisition Corp (BCAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Brookline Capital Acquisition Corp Insider Transactions

No Available Data

What does Apexigen Inc do?

Who are the key executives at Apexigen Inc?

Samuel P Wertheimer is the director of Apexigen Inc. Other key executives at Apexigen Inc include Chief Operating Officer Francis Willard Sarena , Chief Medical Officer Frank J. Hsu , and Chief Financial Officer William E. Duke .

Apexigen Inc (APGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Apexigen Inc (APGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apexigen Inc (APGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Apexigen Inc (APGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apexigen Inc Insider Transactions

No Available Data

What does Brookline Capital Acquisition Corp do?

Who are the key executives at Brookline Capital Acquisition Corp?

Samuel P Wertheimer is the director of Brookline Capital Acquisition Corp. Other key executives at Brookline Capital Acquisition Corp include Chief Operating Officer Francis Willard Sarena , Chief Medical Officer Frank J. Hsu , and Chief Financial Officer William E. Duke .

Brookline Capital Acquisition Corp (BCACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Brookline Capital Acquisition Corp (BCACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Brookline Capital Acquisition Corp (BCACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Brookline Capital Acquisition Corp (BCACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Brookline Capital Acquisition Corp Insider Transactions

No Available Data

Samuel P Wertheimer Mailing Address

Above is the net worth, insider trading, and ownership report for Samuel P Wertheimer. You might contact Samuel P Wertheimer via mailing address: 767 Third Avenue, 30th Floor, New York Ny 10017.

Discussions on Samuel P Wertheimer

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.